Literature DB >> 6436202

Radiation induced failures of complementary metal oxide semiconductor containing pacemakers: a potentially lethal complication.

A A Lewin, C F Serago, J G Schwade, A A Abitbol, S C Margolis.   

Abstract

New multi-programmable pacemakers frequently employ complementary metal oxide semiconductors (CMOS). This circuitry appears more sensitive to the effects of ionizing radiation when compared to the semiconductor circuits used in older pacemakers. A case of radiation induced runaway pacemaker in a CMOS device is described. Because of this and other recent reports of radiation therapy-induced CMOS type pacemaker failure, these pacemakers should not be irradiated. If necessary, the pacemaker can be shielded or moved to a site which can be shielded before institution of radiation therapy. This is done to prevent damage to the CMOS circuit and the life threatening arrythmias which may result from such damage.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6436202     DOI: 10.1016/0360-3016(84)90279-7

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  4 in total

1.  Radiation tolerance of contemporary implantable cardioverter-defibrillators.

Authors:  Michael Mollerus; Leslee Naslund; Margaret Lipinski; Anne Meyer; Bruce Libey; Ken Dornfeld
Journal:  J Interv Card Electrophysiol       Date:  2013-12-07       Impact factor: 1.900

2.  Radiation dose monitoring in a breast cancer patient with a pacemaker: a case report.

Authors:  J R Nibhanupudy; M A de Jesus; M Fujita; A L Goldson
Journal:  J Natl Med Assoc       Date:  2001 Jul-Aug       Impact factor: 1.798

3.  Radiotherapy of patients with cardiac implantable electronic devices according to the DEGRO/DGK guideline-is the risk of relevant errors overestimated?

Authors:  Felix Steger; Matthias G Hautmann; Christoph Süß; Ute Hubauer; Ekrem Ücer; Lars Maier; Oliver Kölbl; Carsten Jungbauer
Journal:  Strahlenther Onkol       Date:  2019-08-09       Impact factor: 3.621

4.  Management and postoperative outcome in primary lung cancer and heart disease co-morbidity: a systematic review and meta-analysis.

Authors:  George D Bablekos; Antonis Analitis; Stylianos A Michaelides; Konstantinos A Charalabopoulos; Anastasia Tzonou
Journal:  Ann Transl Med       Date:  2016-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.